Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | First-choice tablet for type 2 diabetes. | Sulfonylurea that boosts insulin release. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | Biguanides | Sulfonylureas |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Type 2 diabetes, Prediabetes (some countries), Gestational diabetes, Polycystic ovary syndrome (off-label) | Type 2 diabetes |
| How it works | Makes your liver release less sugar and helps your body respond to insulin. | Tells your pancreas to release more insulin. |
| Starts working | Blood sugar improves over 1–2 weeks | — |
| Half-life | About 6 hours | 10–12 hours |
| Typical adult dose | Start 500 mg once or twice a day with meals; increase gradually to 1.5–2 g a day (max 2.55–3 g). | 40–320 mg a day (split if over 160 mg); modified-release 30–120 mg once a day with breakfast. |
| Forms | Tablet, Modified-release tablet, Oral solution, Combination tablets | Tablet, Modified-release tablet |
| Common side effects | Diarrhoea, Nausea, Stomach pain, Metallic taste, Loss of appetite | Low blood sugar, Weight gain, Stomach upset |
| Serious side effects | Lactic acidosis (very rare, mainly with severe kidney failure or acute illness), Vitamin B12 deficiency with long-term use | Severe hypoglycaemia, Liver or blood problems (rare) |
| Don't take if | Severe kidney impairment (eGFR below 30); Acute illness with dehydration, sepsis or shock; Before and after iodinated contrast scans in at-risk patients; Heavy alcohol use or liver disease | Type 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureas; Taking miconazole |
| Alcohol | Best to limit. Heavy drinking raises the risk of lactic acidosis and low blood sugar. | Best to limit. Alcohol raises the risk of severe low blood sugar. |
| Pregnancy | Generally considered safeWidely used for gestational and type 2 diabetes in pregnancy. | Usually avoidedUsually switched to insulin or metformin. |
| Breastfeeding | Generally considered safeConsidered acceptable. | Usually avoidedAvoid; insulin preferred. |
| In use since | 1957 | 1972 |
| Brand names | United States: Glucophage, GlumetzaUnited Kingdom: Glucophage, Sukkarto SRIndia: Glycomet, Glyciphage, Obimet | United Kingdom: Diamicron, ZicronIndia: Glizid, Reclide, DiamicronAustralia: Diamicron MR |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | A10BA02 | A10BB09 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker